AzTrials
AzTrials

Research institution

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Clinical Trials

Studies where Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine is the lead sponsor: what is enrolling now, by phase, condition and country.

182 registered studies

In numbers

Open to volunteers
98
Active
99
With results posted
1
All registered
182

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 98
  • Myelodysplastic Syndromes, High Risk

    Sonrotoclax Plus Azacitidine in Patients With MDS-IB2

    • Recruiting
    • Age: 18 to 70 years
    • Phase 1/2

    This study will evaluate the safety and preliminary effectiveness of sonrotoclax combined with azacitidine in adults aged 18-70 years with newly diagnosed myelodysplastic neoplasms with increased blasts-2 (MDS-IB2).

    Trial name
    NCT07885397
    Testing
    Sonrotoclax, Azacitidine (AZA)
    Where
    6 sites in China
    Volunteers
    60 people
    Sponsor
    Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
    Can I take part? NCT07885397
  • Pancreatic Ductal Adenocarcinoma (PDAC)

    Clinical Study of Radiotherapy Combined With Adebrelimab and NALIRIFOX for Conversion Therapy in Locally Advanced Pancreatic Cancer

    • Not yet recruiting
    • Age: 18 to 85 years
    • Phase 2
    • Surgery or procedure

    This study intends to explore conversion therapy for locally advanced pancreatic cancer (LAPC). The intervention starts with modified stereotactic body radiation therapy (3-day regimen), followed by systemic therapy within 1-2…

    Trial name
    NCT07827053
    Testing
    Adebrelimab (PD-L1 inhibitor), NALIRIFOX, SBRT
    Volunteers
    36 people
    Sponsor
    Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
    Can I take part? NCT07827053
  • Glaucoma, Exercise

    Visual Function and Exercise in Glaucoma Patients

    • Not yet recruiting
    • Age: 18 to 100 years
    • Observational study

    This study will investigate the relationship between visual function-including central visual field, the retinal nerve fiber layer (RNFL) in the macular and optic disc regions, intraocular pressure, and other factors-and exercise…

    Trial name
    NCT07824232
    Testing
    answer questionnaire
    Where
    China
    Volunteers
    100 people
    Sponsor
    Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
    Can I take part? NCT07824232
  • Urolithiasis, Strategy Training

    Real-World Study of Obstructive Upper Urinary Tract Stones and Acute Pyelonephritis

    • Not yet recruiting
    • Age: 18 years and older
    • Observational study
    • Surgery or procedure

    Upper urinary tract stone obstruction complicated by acute pyelonephritis is a critical urological emergency requiring urgent decompression and infection control, yet real-world clinical decisions regarding the choice between…

    Conditions
    Urolithiasis, Strategy Training, Observation, Pyelonephritis Acute
    Trial name
    NCT07816991
    Testing
    Ureteral Stent, Percutaneous Nephrostomy, Initial Medical Therapy
    Volunteers
    1,650 people
    Sponsor
    Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
    Can I take part? NCT07816991
  • Iliofemoral Vein Stenosis, Iliofemoral Vein Occlusion

    Vflower Stent System for Iliofemoral Vein Stenosis and Occlusion: A Multicenter Real-World Study

    • Not yet recruiting
    • Age: 18 years and older
    • Observational study
    • Medical device

    This multi-center, real-world observational study is being conducted at five hospitals in China to evaluate the effectiveness of the Vflower venous stent system in patients with iliofemoral vein stenosis or occlusion.

    Trial name
    V-STAR (NCT07809204)
    Testing
    Vflower venous stent system (self-expanding nitinol stent for iliofemoral venous lesions)
    Volunteers
    310 people
    Sponsor
    Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
    Can I take part? V-STAR
  • Breast Cancer

    Evaluation of the Safety and Efficacy of Single-Port Robot-Assisted Endoscopic Breast-Conserving Surgery and Nipple-sparing Matectomy With Reconstruction in Early-Stage Breast Cancer Patients

    • Not yet recruiting
    • Age: 18 to 80 years
    • Surgery or procedure

    This study is testing a new, less invasive way to perform breast cancer surgery using a single-port robotic system (a robot-assisted surgical tool made in China, called the Shurui SR-ENS-600).

    Trial name
    NCT07781163
    Testing
    single-port robot-assisted surgery
    Volunteers
    30 people
    Sponsor
    Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
    Can I take part? NCT07781163
  • Intraocular Pressure

    Safety, Tolerability, and Accuracy of a Hydrogel-Based Wearable Dynamic Intraocular Pressure Sensor in Healthy Adults

    • Not yet recruiting
    • Age: 20 to 40 years
    • Medical device

    The occurrence and progression of eye diseases like glaucoma are closely related to intraocular pressure fluctuations. Traditional single-point intraocular pressure measurement methods cannot reflect daily dynamic changes and are…

    Trial name
    NCT07770178
    Testing
    Hydrogel-Based Wearable Dynamic Intraocular Pressure Sensor
    Where
    China
    Volunteers
    20 people, healthy volunteers welcome
    Sponsor
    Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
    Can I take part? NCT07770178
  • Pancreatic Cancer, Pancreatic Cancer Metastatic

    Study on the Construction and Application of a Large Model Corpus for Pancreatic Cancer Based on Real Clinical Cases

    • Not yet recruiting
    • Age: 18 years and older
    • Observational study

    Combining retrospective observational research with artificial intelligence data engineering. Collecting historical electronic medical record data, and through data governance and annotation by artificial medical experts…

    Conditions
    Pancreatic Cancer, Pancreatic Cancer Metastatic, Pancreatic Cancer Non-resectable, Pancreatic Cancer Resectable
    Trial name
    NCT07713823
    Volunteers
    3,000 people
    Sponsor
    Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
    Can I take part? NCT07713823
  • Head and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC)

    Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

    • Recruiting
    • Age: 18 to 75 years
    • Phase 2
    • Injection or infusion
    • Surgery or procedure

    This is a randomized controlled, phase II clinical study designed to explore the efficacy and safety of nimotuzumab combined with immunotherapy and chemotherapy as neoadjuvant treatment for locally advanced head and neck squamous…

    Conditions
    Head and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Head & Neck Cancer, Neoadjuvant Therapy
    Trial name
    NCT07601737
    Testing
    Nimotuzumab Injection, Tislelizumab, Albumin-Bound Paclitaxel /nab-Paclitaxel
    Where
    China
    Volunteers
    182 people
    Sponsor
    Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
  • Acute Wheezing Disorders in Infants Aged 0 to 24 Months

    Efficacy and Safety of Fluticasone Propionate Nebulized Suspension for Wheezing Diseases in Infants Aged 0-24 Months

    • Not yet recruiting
    • Age: 0 to 24 months
    • Phase 4

    This study looks at how well and how safe fluticasone propionate nebulized suspension works in babies aged 0 to 24 months who have acute wheezing.

    Trial name
    FPNS-IWD (NCT07675252)
    Testing
    Fluticasone Propionate Nebulization, Budesonide Nebulization
    Volunteers
    240 people
    Sponsor
    Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
    Can I take part? FPNS-IWD

Completed, with results posted

All 1
  • Esophageal Cancer

    Radiation Dose Escalation in Esophageal Cancer

    • Completed
    • Age: 18 to 75 years
    • Surgery or procedure
    • Results posted

    The aim of this trial is to find the maximum tolerable dose of radiation that can be delivered combined with chemotherapy (DDP \& Paclitaxel) in patients with inoperable or medically unresectable esophageal cancer.

    Trial name
    NCT03082586
    Testing
    radiochemotherapy 1, radiochemotherapy 2, radiochemotherapy 3
    Where
    China
    Volunteers
    31 people
    Sponsor
    Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
    Can I take part? NCT03082586

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in